IBDEI1EW ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25315,0)
 ;;=V19.0^^145^1538^5
 ;;^UTILITY(U,$J,358.3,25315,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25315,1,4,0)
 ;;=4^V19.0
 ;;^UTILITY(U,$J,358.3,25315,1,5,0)
 ;;=5^Family h/o Blindness
 ;;^UTILITY(U,$J,358.3,25315,2)
 ;;=^295320
 ;;^UTILITY(U,$J,358.3,25316,0)
 ;;=V16.3^^145^1538^6
 ;;^UTILITY(U,$J,358.3,25316,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25316,1,4,0)
 ;;=4^V16.3
 ;;^UTILITY(U,$J,358.3,25316,1,5,0)
 ;;=5^Family h/o Cancer of Breast
 ;;^UTILITY(U,$J,358.3,25316,2)
 ;;=^295295
 ;;^UTILITY(U,$J,358.3,25317,0)
 ;;=V16.41^^145^1538^9
 ;;^UTILITY(U,$J,358.3,25317,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25317,1,4,0)
 ;;=4^V16.41
 ;;^UTILITY(U,$J,358.3,25317,1,5,0)
 ;;=5^Family h/o Cancer of Ovary
 ;;^UTILITY(U,$J,358.3,25317,2)
 ;;=^317951
 ;;^UTILITY(U,$J,358.3,25318,0)
 ;;=V16.42^^145^1538^10
 ;;^UTILITY(U,$J,358.3,25318,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25318,1,4,0)
 ;;=4^V16.42
 ;;^UTILITY(U,$J,358.3,25318,1,5,0)
 ;;=5^Family h/o Cancer of Prostate
 ;;^UTILITY(U,$J,358.3,25318,2)
 ;;=^317952
 ;;^UTILITY(U,$J,358.3,25319,0)
 ;;=V16.43^^145^1538^11
 ;;^UTILITY(U,$J,358.3,25319,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25319,1,4,0)
 ;;=4^V16.43
 ;;^UTILITY(U,$J,358.3,25319,1,5,0)
 ;;=5^Family h/o Cancer of Testis
 ;;^UTILITY(U,$J,358.3,25319,2)
 ;;=^317953
 ;;^UTILITY(U,$J,358.3,25320,0)
 ;;=V19.5^^145^1538^13
 ;;^UTILITY(U,$J,358.3,25320,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25320,1,4,0)
 ;;=4^V19.5
 ;;^UTILITY(U,$J,358.3,25320,1,5,0)
 ;;=5^Family h/o Congenital Anomalies
 ;;^UTILITY(U,$J,358.3,25320,2)
 ;;=^295325
 ;;^UTILITY(U,$J,358.3,25321,0)
 ;;=V19.2^^145^1538^14
 ;;^UTILITY(U,$J,358.3,25321,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25321,1,4,0)
 ;;=4^V19.2
 ;;^UTILITY(U,$J,358.3,25321,1,5,0)
 ;;=5^Family h/o Deafness Or Hearing Loss
 ;;^UTILITY(U,$J,358.3,25321,2)
 ;;=^295322
 ;;^UTILITY(U,$J,358.3,25322,0)
 ;;=V17.3^^145^1538^16
 ;;^UTILITY(U,$J,358.3,25322,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25322,1,4,0)
 ;;=4^V17.3
 ;;^UTILITY(U,$J,358.3,25322,1,5,0)
 ;;=5^Family h/o Ischemic Heart Dis
 ;;^UTILITY(U,$J,358.3,25322,2)
 ;;=^295305
 ;;^UTILITY(U,$J,358.3,25323,0)
 ;;=V16.6^^145^1538^17
 ;;^UTILITY(U,$J,358.3,25323,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25323,1,4,0)
 ;;=4^V16.6
 ;;^UTILITY(U,$J,358.3,25323,1,5,0)
 ;;=5^Family h/o Leukemia
 ;;^UTILITY(U,$J,358.3,25323,2)
 ;;=^295298
 ;;^UTILITY(U,$J,358.3,25324,0)
 ;;=V18.61^^145^1538^19
 ;;^UTILITY(U,$J,358.3,25324,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25324,1,4,0)
 ;;=4^V18.61
 ;;^UTILITY(U,$J,358.3,25324,1,5,0)
 ;;=5^Family h/o Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,25324,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,25325,0)
 ;;=V17.0^^145^1538^20
 ;;^UTILITY(U,$J,358.3,25325,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25325,1,4,0)
 ;;=4^V17.0
 ;;^UTILITY(U,$J,358.3,25325,1,5,0)
 ;;=5^Family h/o Psychiatric Condition
 ;;^UTILITY(U,$J,358.3,25325,2)
 ;;=^295302
 ;;^UTILITY(U,$J,358.3,25326,0)
 ;;=V19.4^^145^1538^21
 ;;^UTILITY(U,$J,358.3,25326,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25326,1,4,0)
 ;;=4^V19.4
 ;;^UTILITY(U,$J,358.3,25326,1,5,0)
 ;;=5^Family h/o Skin Condition
 ;;^UTILITY(U,$J,358.3,25326,2)
 ;;=^295324
 ;;^UTILITY(U,$J,358.3,25327,0)
 ;;=V17.1^^145^1538^22
 ;;^UTILITY(U,$J,358.3,25327,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25327,1,4,0)
 ;;=4^V17.1
 ;;^UTILITY(U,$J,358.3,25327,1,5,0)
 ;;=5^Family h/o Stroke (CVA)
 ;;^UTILITY(U,$J,358.3,25327,2)
 ;;=^295303
 ;;^UTILITY(U,$J,358.3,25328,0)
 ;;=V16.8^^145^1538^12
 ;;^UTILITY(U,$J,358.3,25328,1,0)
 ;;=^358.31IA^5^2
